LEADER 02427nam 2200553z- 450 001 9910557466503321 005 20231214133156.0 035 $a(CKB)5400000000043133 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/73103 035 $a(EXLCZ)995400000000043133 100 $a20202111d2019 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFrontiers in Oncology: Quarterly Highlights: Q1 2019 210 $cFrontiers Media SA$d2019 215 $a1 electronic resource (213 p.) 311 $a2-88945-939-X 330 $aThis eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact 517 $aFrontiers in Oncology 606 $aMedicine$2bicssc 606 $aOncology$2bicssc 610 $aCancer Epidemiology and Prevention 610 $acancer genetics 610 $aCancer Imaging and Image-directed Interventions 610 $aCancer Immunity and Immunotherapy 610 $aMolecular Targets and Therapeutics 610 $aGastrointestinal cancers 610 $aGenitourinary oncology 610 $ahead and neck cancer 610 $aHematologic Malignancies Metabolism 610 $amolecular and cellular oncology 610 $aNeuro-Oncology and Neurosurgical Oncology 610 $apediatric oncology 610 $aPharmacology of Anti-Cancer Drugs 610 $aRadiation Oncology 610 $asurgical oncology 610 $athoracic oncology 610 $awomen's cancer 615 7$aMedicine 615 7$aOncology 700 $aGiaccone$b Giuseppe$4edt$081337 702 $aGiaccone$b Giuseppe$4oth 906 $aBOOK 912 $a9910557466503321 996 $aFrontiers in Oncology: Quarterly Highlights: Q1 2019$93031052 997 $aUNINA